FDA analysis revealing that these dietary supplements contain undeclared drug products making them unapproved drugs.
L'Agenzia Europea per i Medicinali (EMA) ha avviato una rivalutazione
degli spray per uso nasale e orale contenenti l’antibiotico fusafungina,
utilizzato per trattare le infezioni delle vie respiratorie superiori,
come sinusite (infezione dei seni paranasali) e tonsilliti
(infiammazione delle tonsille causate da un'infezione).
FDA added a new Warning and Precaution and revised the Adverse Reactions section of the Invokana and Invokamet drug labels.
Administration of a non-sterile drug product intended to be sterile may result in serious and potentially life-threatening infections or death.
An interaction with the rubber stopper in certain lots of these syringes can cause some drugs stored in these syringes to lose potency if filled and not used immediately.
L'Agenzia Italiana del Farmaco comunica nuove e importanti informazioni sull'uso di Betmiga (mirabegron).
A pair of adverse reactions
Appropriate prescription of drugs in elderly patients is one of the biggest current challenges in clinical geriatrics. As is already known, the elderly often have multiple concomitant chronic conditions (multi-morbidities), which require the simultaneous use of multiple drugs (polypharmacy), which carries an increased risk of drug interactions and thus of adverse reactions.1
Earlier this year, at the presentation of the OsMed/AIFA report on drug consumption in Italy, health Minister Lorenzin expressed "grave concern at the increased consumption of opiates." Are Minister's concerns justified? Were we not the country with one of the lowest morphine consumption rates in the world? What has changed? Where did this "grave concern" come from?
Consumption in Italy
In Europe, according to the European Monitoring Centre (EMCDDA, 2013)1, 22% (70 million) of those aged between 15 and 64 years have used cannabis preparations (mainly marijuana) for recreational purposes at least once in their lifetime, 7% (23 million) within the last year, and 4% (14 million) within the last month. These percentages increase (17%) when considering use in the last year, in the age range 15-24 years.
80.211.154.110
